Whalegun
Home

Bahram Valamehr, Chief R&D Officer: Fate Therapeutics FATE Sell · Filed 24/01/10

Trade details

Type
Insider sale
Amount
$49,366.98
Shares · price
11,271 sh · $4.38 a share
Held after
158,069 sh
Stock
Fate Therapeutics FATE
Person
Bahram ValamehrChief R&D Officer
Trade date
24/01/09
Filed
24/01/10
Days to filing
1 days

Sold 6.7% of holdings

Share of holding sold
6.7%

Fate Therapeutics trades, last 26 weeks

What else happened in Fate Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/10~24/02/08

Bahram Valamehr's recent trades

  • Bahram Valamehr

    Planned saleFate Therapeutics

    $108.1K

    Filed 08/04

  • Bahram Valamehr

    SellFate Therapeutics

    $54.4K

    Filed 05/21

  • Bahram Valamehr

    Planned saleFate Therapeutics

    $54.5K

    Filed 05/20

  • Bahram Valamehr

    SellFate Therapeutics

    $5,553

    Filed 01/12

  • Bahram Valamehr

    Planned saleFate Therapeutics

    $5,557

    Filed 01/09

Bahram Valamehr, Chief Officer — sold $49.4K of Fate Therapeutics FATE · 6.7% of holdings | Whalegun